89bio
Price & Volume
Stats
See moreOpen | $8.45 |
Previous Close | $8.38 |
Day Range | $8.35-$8.50 |
52W Range | $7-$16.63 |
Market Cap | $985.3M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.96 |
News
See moreYahoo Finance • 6 months ago
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Yahoo Finance • 9 months ago
11 Best Small-Cap Growth Stocks to Invest In
Yahoo Finance • 12 months ago
89bio Announces New Positive Long-Term Data from the ENLIVEN Phase 2b Trial of Pegozafermin in Patients with Nonalcoholic Steatohepatitis (NASH)
Yahoo Finance • last year
89bio to Participate in the 6th Annual Evercore ISI HEALTHCONx Conference
About
CEO | Mr. Rohan Palekar |
Address | 142 Sansome Street, San Francisco, CA, United States, 94104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
